Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2011 · Health Technology Assessment · 134 citations
https://doi.org/10.3310/hta15100
L
Laura Bojke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
3.7K
Citations
32
h-index
64
i10-index
Laura Bojke is an academic researcher. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Spondyloarthritis Studies and Treatments & Healthcare cost, quality, practices. The author has an h-index of 32, co-authored 138 publications.
ORCID: 0000-0001-7921-9109Papers by this author
worksThe Internet for weight control in an obese sample: results of a randomised controlled trial
2007 · BMC Health Services Research · 129 citations
https://doi.org/10.1186/1472-6963-7-206
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
2017 · Health Technology Assessment · 44 citations
https://doi.org/10.3310/hta21560
The cost-effectiveness of population Health Checks: have the NHS Health Checks been unfairly maligned?
2017 · Journal of Public Health · 21 citations
https://doi.org/10.1007/s10389-017-0801-8
A discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis
2016 · Clinical Rheumatology · 12 citations
https://doi.org/10.1007/s10067-016-3452-1
Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party
2015 · Rheumatology and Therapy · 11 citations
https://doi.org/10.1007/s40744-015-0020-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat